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ABSTRACT
Next-generation sequencing (NGS) technologies en-
able new insights into the diversity of virus popula-
tions within their hosts. Diversity estimation is cur-
rently restricted to single-nucleotide variants or to
local fragments of no more than a few hundred nu-
cleotides defined by the length of sequence reads.
To study complex heterogeneous virus populations
comprehensively, novel methods are required that
allow for complete reconstruction of the individual
viral haplotypes. Here, we show that assembly of
whole viral genomes of ∼8600 nucleotides length
is feasible from mixtures of heterogeneous HIV-1
strains derived from defined combinations of cloned
virus strains and from clinical samples of an HIV-
1 superinfected individual. Haplotype reconstruction
was achieved using optimized experimental proto-
cols and computational methods for amplification,
sequencing and assembly. We comparatively as-
sessed the performance of the three NGS platforms
454 Life Sciences/Roche, Illumina and Pacific Bio-
sciences for this task. Our results prove and de-
lineate the feasibility of NGS-based full-length viral
haplotype reconstruction and provide new tools for
studying evolution and pathogenesis of viruses.
INTRODUCTION
Assessing the genetic diversity of intra-host pathogen pop-
ulations has gained increasing interest in recent years. Es-
pecially viruses with high mutation rates and short repli-
cation cycles, such as human immunodeficiency virus type
1 (HIV-1), rapidly develop highly diverse intra-host popu-
lations, called viral quasispecies (1,2). To estimate the di-
versity of a viral quasispecies, next-generation sequencing
(NGS) technologies can be applied, which produce thou-
sands to millions of sequence reads in one run from amixed
sample.
Different NGS technologies are available, among them
pyrosequencing by 454 Life Sciences/Roche (454/Roche),
reversible terminator sequencing-by-synthesis by Illumina
and single-molecule sequencing by Pacific Biosciences
(PacBio) (3). They differ in sequencing chemistry, speed,
throughput, read length, error rates and error patterns.
Each of the three technologies can be used to analyze vi-
ral genomes, but none enables sequencing regions larger
than a few hundred bases with sufficiently high accuracy.
Consequently, virus diversity is typically assessed only by
studying single nucleotide positions or mutations within
a read length (4–10). Genome-wide reconstruction was
only achieved with simulated data in silico, so far (11–
14). Therefore, experimental amplification and sequencing
strategies, combined with appropriate bioinformatics meth-
ods for haplotype inference, are needed to phase multiple
*To whom correspondence should be addressed. Tel: +41 44 255 3029; Fax: +41 44 255 3291; Email: Karin.Metzner@usz.ch
Correspondence may also be addressed to Volker Roth. Tel: +41 61 267 0549; Fax: +41 61 267 0559; Email: volker.roth@unibas.ch
Correspondence may also be addressed to Niko Beerenwinkel. Tel: +41 61 387 3169; Fax: +41 61 387 39 90; Email: niko.beerenwinkel@bsse.ethz.ch
†The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors.
C© The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which
permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact
journals.permissions@oup.com
e115 Nucleic Acids Research, 2014, Vol. 42, No. 14 PAGE 2 OF 12
overlapping sequence reads, and to allow reconstruction of
whole genomes. HIV-1 is an attractive model system for de-
veloping such a global haplotype inference methodology
due to its small genome, high intra-patient genetic diversity
and clinical relevance.
Virus populations do not qualify for recent single-cell ge-
nomics approaches that have been applied to cancer cells
and to somemicrobes (15), because these techniques require
single-cell separation prior to genome amplification. Up to
now, this segregation is not feasible for viruses, because they
are too small. Thus, characterizing viral quasispecies has to
rely on the analysis of assorted samples. The challenge is
then to reliably solve a jigsaw puzzle of short error-prone
sequence reads and to reconstruct the different constituent
haplotypes over long genomic regions (16). Errors can oc-
cur at each of the required steps of viral genome amplifi-
cation and during sequencing. Furthermore, estimating the
relative frequencies of the viral haplotypes in the popula-
tion is affected by amplification biases due to, for instance,
primermismatches and in vitro recombination (17). Special-
ized bioinformatics tools have been developed to cope with
these error-proneNGS data and to reconstruct, from amul-
tiple sequence alignment of reads, the haplotypes that con-
stitute the viral population within a single host (16). Multi-
ple read alignment can introduce additional uncertainty by
placing insertions and deletions ambiguously.
To test genome-wide haplotype reconstruction on real
data, we first combined five HIV-1 strains in a large batch
to obtain similar aliquots of one mixture of heterogeneous
viral haplotypes. In a second step to evaluate our analyti-
cal approach in a relevant clinical setting, we longitudinally
studied a well-characterized HIV-1 infected individual who
during the course of infection acquired a new viral strain
by superinfection as documented by clonal sequencing of
the partial env gene which encodes the viral envelope. The
three NGS technologies 454/Roche, Illumina and PacBio
were applied to sequence the full-length genomes of the five
distinct HIV-1 strains, each requiring different protocols for
sample preparation and sequencing.We usedQuasiRecomb
(18) and PredictHaplo (19) to correct sequencing errors, re-
construct the viral variants locally (within one read length)
and globally (connecting overlapping reads).
MATERIALS AND METHODS
Viruses
293T cells were transfected separately with five differ-
ent HIV-1 full-length plasmids using LipofectamineTM2000
(Invitrogen, Zug) according to the manufacturer’s proto-
col. The HIV-1 full-length plasmids were obtained through
the NIH AIDS Research and Reference Reagent Program,
Division of AIDS, NIAID, NIH: pYK-JRCSF from Irvin
S.Y. Chen and Yoshio Koyanagi; pNL4–3 from Malcolm
Martin; pYU2 from Beatrice Hahn and George M. Shaw;
p89.6 fromRonaldG. Collman and pHXB2was kindly pro-
vided by Marek Fischer. Cell supernatants were collected
48 h post-transfection after centrifugation for 5 min at
3000 revolutions per minute and then filtered through 0.22
m Sterilflip R© (Millipore, Zug) to obtain cell-free virus
stocks. The virus stocks were quantified by real-time poly-
merase chain reaction (PCR) and pooled in approximate
same amounts to obtain the 5-virus-mix, whose virus titer
was 6.67 × 106 HIV-1 RNA copies/ml cell culture super-
natant, as previously described (20). Numerous aliquots of
this mix of intact virus particles were stored at −80◦C.
Patient’s samples were processed accordingly. This pa-
tient participates in the Zurich Primary HIV Infection
(ZPHI) study, which is an observational, open label, non-
randomized, single center study (www.clinicaltrials.gov; ID
NCT00537966) (21,22). Written informed consent was ob-
tained from the patient prior to inclusion.
HIV-1 full-length genome sequencing using the 454 Life
Sciences/Roche platform
Approximately 106 HIV-1 RNA copies were isolated from
the virus particles in the 5-virus-mix using theNucleoSpin R©
RNA Virus Kit (Macherey and Nagel, Oensingen) accord-
ing to the manufacturer’s protocol and eluted in 60 l
water. RNA was treated with 5 U DNase (DNase I re-
combinant, RNase-free; Roche, Mannheim) at 25◦C for
30 min followed by 70◦C for 15 min and then separated
into three reverse transcription reactions, each contain-
ing 9.2 l DNase treated RNA and a mix of 12 or 11
oligonucleotides for cDNA syntheses (0.2 M end concen-
tration for each oligonucleotide) (Supplementary Table S1).
RNA plus oligonucleotide-mix was incubated at 65◦C for
10 min followed by cooling at 4◦C for 2 min. cDNA synthe-
sis was performed with Transcriptor High Fidelity cDNA
System (Roche) according to the manufacturer’s protocol.
The cDNA was treated with RNase H (New England Bi-
olabs, Bioconcept, Allschwil) following the manufacturer’s
instructions. PCRs were performed using 5 l of cDNA
in a total volume of 30 l: 94◦C-5′, 30–35 x (94◦C-15′′,
57◦C-45′′, 72◦C-60′′) containing 0.4 mM dNTPs (Fermen-
tas,Mont-sur-Lausanne), 3 UFastStart High Fidelity Poly-
merase (Roche) and 0.32 M of each forward oligonu-
cleotide primer A (5′–CGTATCGCCTCCCTCGCGCCA-
TCAG-HIV-1–3′) and reverse oligonucleotide primer B (5′–
CTATGCGCCTTGCCAGCCCGC-TCAG-HIV-1–3′) in-
cluding A and B sequences at the 5′-ends necessary for the
454/Roche FLX/Titanium pyrosequencing method; HIV-1
specific oligonucleotide sequences are listed in Supplemen-
tary Table S1. All amplicons were gel purified and quanti-
fied with the Quant-iTTM PicoGreen R© dsDNA Assay (In-
vitrogen). Equimolar amounts of gel-purified amplicons
were pooled, clonally amplified on capture beads and se-
quenced using two large regions of of a 70 × 75 mm Pi-
coTiterPlate. The standard bidirectional Amplicon proto-
col (LibA)was followed according tomanufacturer’s guide-
lines (454 Life Sciences/Roche, Branford).
HIV-1 full-length genome sequencing using the Illumina plat-
form
Approximately 105 HIV-1 RNA copies were isolated as de-
scribed above except that the DNase treatment was done
on the column after the first washing step and RNA was
eluted in 25 l water. Two multiplexed cDNA synthesis re-
actions were done with 10 l DNase treated RNA contain-
ing two and three specific oligonucleotides (1 M) and 0.5
mM dNTPs (Supplementary Table S1) were added and the
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mix was incubated at 65◦C for 5 min followed by cooling
at 4◦C for 2 min. Reverse transcription was performed us-
ing the following conditions: 5x reaction buffer (Clontech,
Saint-Germain-en-Laye), 20 U Protector RNase Inhibitor
(Roche), 200 U PrimeScript Reverse Transcriptase (Clon-
tech) and water to a total volume of 20 l. The reaction
mix was incubated at 42◦C for 60 min followed by 70◦C
for 15 min. The cDNA was treated with RNase H (New
England Biolabs) following themanufacturer’s instructions.
Five PCRs were performed with 2 l of cDNA using 1
U of Platinum R© Taq DNA Polymerase High Fidelity (In-
vitrogen), 0.4 mM of each dNTP and 0.5 M oligonu-
cleotides (Supplementary Table S1). The PCR cycling con-
ditions were 94◦C-2′, 35 x (94◦C-30′′, 55◦C-30′′, 68◦C-
2′40′′). PCR products were purified with the Agencourt
AMPure XP PCR Purification (Beckman Coulter, Krefeld)
following the manufacturer’s instructions and quantified as
described above. The sequencing library was prepared with
the Nextera XT DNA Sample Preparation Kit (Illumina,
SanDiego) according to themanufacturer’s description and
sequenced using a MiSeq Benchtop Sequencer generating
paired-end reads of 2×250 bp length (v2 kit).
HIV-1 full-length genome sequencing using the Pacific Bio-
sciences platform
Approximately 105 HIV-1 RNA copies were isolated as de-
scribed above (Illumina). Five separate cDNA synthesis re-
actions were performed with 10 l of DNase treated RNA,
1.2 mM of each dNTP and 0.6 M oligonucleotide (Sup-
plementary Table S1). The mix was incubated at 65◦C for 5
min and 4◦C for 2min. cDNA synthesis was performedwith
200 U of PrimeScript Reverse Transcriptase (Clontech) and
20 U Protector RNase Inhibitor (Roche) in a total volume
of 20l at 42◦C for 60 min and 70◦C for 15 min. The cDNA
was treated with RNase H (New England Biolabs) fol-
lowing the manufacturer’s instructions. Eleven PCRs were
performed with 2 l cDNA using 0.4 U PlatinumR© Taq
DNA Polymerase High Fidelity, 10x PCR reaction buffer,
2 mM MgSO4 (Invitrogen), 0.4 mM of each dNTP and
0.5 M oligonucleotides (Supplementary Table S1). The
PCR cycling conditions were 94◦C-2′, 25–28 x (94◦C-30′′,
58◦C-30′′, 68◦C-110′′). PCR products were purified using
NucleoSpin R© Gel and PCRClean-up (Machery andNagel,
Oensingen) following the manufacturer’s instructions and
purity was verified with the Bioanalyzer DNA 12000 Kit
(Agilent Technologies, Basel). DNA was quantified as de-
scribed above and amplicons were pooled to a total quan-
tity of 2 g. The pool was treated with PreCRR© RepairMix
(New England Biolabs) to repair any DNA damage and the
sequencing library was prepared using the DNA Template
Prep Kit 2.0 (250 bp ≤ 3 kb) (Pacific Biosciences, Menlo
Park), following the manufacturer’s instructions. The Pa-
cific Biosciences RS instrument was programmed to load
the libraries on PacBio SMRT cells using the standard dif-
fusion method. The circular consensus sequencing method
has been used to ensure lower error rates. In order to achieve
long read length, long movies of 120 min were taken.
HIV-1 full-length genome sequencing of clinical samples
Two clinical samples from an HIV-1 infected patient were
used for HIV-1 full-length genome sequencing using both
the Illumina (2×300 bp, v3 kit) and the Pacific Biosciences
platforms. Sample preparation was performed as for the 5-
virus-mix, except that 1 ml of plasma was centrifuged for 1
h at 50 000 g prior to RNA isolation. The cDNA synthe-
sis was performed in two parallel reactions, each with three
RT oligonucleotides (Supplementary Table S2), followed by
nested or semi-nested PCR for the amplification of 5 and 11
amplicons, respectively (Supplementary Table S2).
Clonal env sequencing
Full length envelope single genome amplicons were de-
rived from plasma virus by RNA extraction followed by
DNase treatment (RNeasy, Qiagen, Hombrechtikon), re-
verse transcription using RT Superscript III (Invitrogen
AG, Basel) and nested PCR amplification of diluted cDNA
using Platinum Taq high fidelity polymerase (Invitrogen).
For each sample 36 appropriate end-point dilutions con-
taining ∼0.5 cDNA templates as determined by quanti-
tative real-time PCR of the tat-rev-vpu region were pro-
cessed. Bidirectional sequencing of 10 overlapping regions
by dye terminator cycle sequencing (ABI Prism BigDye,
Applied Biosystems, Rotkreuz) was accomplished as previ-
ously described (23). Sequences were assembled with Seq-
Man (DNASTAR Inc., MadisonWI), checked for ambigu-
ities, premature stop codons and hypermutations (www.hiv.
lanl.gov/content/sequence/HYPERMUT) and analyzed by
using BioEdit 7, Phylip 3.68 and MEGA 5.
Alignment
The read data sets from the three NGS platforms
454/Roche, Illumina and PacBio, were converted to fastq
files. For 454/Roche and PacBio, the InDelFixer software
(http://www.cbg.ethz.ch/software/InDelFixer/) was used to
first extract reads and to perform quality clipping from
both ends of the reads with a PHRED threshold of 30.
Second, adaptors were removed and approximate match-
ing regions were found in the reference genome using k-mer
matching. Subsequently, each read was pairwise aligned to
the HIV-1HXB2 reference sequence using a sensitive Smith–
Waterman algorithm to create a multiple sequence align-
ment discarding insertions. Exchanging the HIV-1HXB2 ref-
erence sequence has no influence on the alignment result as
long as the same HIV-1 subtype is chosen. For the Illumina
data set, quality clipping was performed with sickle (https:
//github.com/najoshi/sickle) and alignments were produced
with the Burrows–Wheeler Aligner BWA mem algorithm.
Reads were discarded if three or more consecutive N base
calls were present or if the read length was less than 150 nt,
300 nt and 1000 nt for Illumina, 454/Roche and PacBio, re-
spectively.
Global haplotype reconstruction
Viral haplotype reconstruction of the 5-virus-mix was per-
formed with the quasispecies assembly tool QuasiRecomb
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1.2 (www.cbg.ethz.ch/software/quasirecomb) (18) employ-
ing the flags ‘-conservative’, because our focus was on dom-
inant haplotypes, ‘-noRecomb’, as the underlying popu-
lation structure was not subjected to recombination and
the runtime reduced, and ‘-t 500’, specifying the number
of restarts of the inference algorithm. In regions that are
not known to harbor deletions ‘-noGaps’ was employed to
weight down gaps and to increase convergence. For the clini-
cal sample, QuasiRecombwas executedwith default param-
eters. QuasiRecomb implements a hiddenMarkov model to
infer a viral quasispecies from deep-coverage NGS data us-
ing an expectation maximization (EM) algorithm for max-
imum a posteriori (MAP) parameter estimation. It takes
paired-end information explicitly into account. The model
assumes that a complex quasispecies emerges from a few
dominating haplotypes, called generators and represented
as position-wise base probability distributions. Model se-
lection, i.e. determining the number of generators, was per-
formed gene-wise and five generators were always selected
by the model without prior knowledge for the 5-virus-mix,
unless haplotypes were missing. These generators, i.e. their
mode, represented the haplotypes in the underlying quasis-
pecies. The efficiency of global haplotype reconstruction is
improved by informed generator initialization in the EM
algorithm. We constructed initial generators hierarchically
from previously reconstructed subregions by generating all
combinations of the subregion haplotypes. For each com-
bination, 10 random restarts were considered with initial
generator probability tables drawn from Dirichlet distribu-
tions centered around each combined haplotype sequence,
and the best combination was selected. Another 50 random
restarts with initial generators randomized from the opti-
mal combination were then used to find the final MAP esti-
mates. All combinations of haplotypes were generated using
‘-mix -i region1.fasta -h region2.fasta’ and a specific initial-
ization can be usedwith ‘-initMu haplotypes.fasta’. This ap-
proach is used for regions >1.5 kb, >2 kb and >5 kb, for
Illumina, 454/Roche and PacBio, respectively.
Global haplotype reconstruction over long genomic re-
gions, including genome-wide quasispecies assembly, was
also performed with the PredictHaplo software, version 1.0
(http://bmda.cs.unibas.ch/HivHaploTyper/). PredictHaplo
implements a fully probabilistic approach to quasispecies
reconstruction. Given a set of aligned reads, its built-in
Bayesian mixture model with a Dirichlet process prior al-
lows for adaptively estimating the unknown number of un-
derlying haplotypes. Inference is carried out via a Markov
chain Monte Carlo sampling scheme that was optimized to
scale with real-world NGS data sets. The reliability of a re-
constructed haplotype sequence is estimated via an internal
quality score which measures the amount of overlap of the
subset of reads assigned to this sequence. The reconstruc-
tion process starts by locally clustering the aligned reads
in order to identify the region with the highest number of
high-quality clusters. This region then serves as a seed for
globally reconstructing the quasispecies by propagating the
mixture model. Once this process is completed, the internal
quality scores are used for identifying reliable variant se-
quences. Prior parameters and threshold values have been
set based on simulated data produced by the MetaSim pro-
gram (24).
RESULTS
Experimental design
We combined five HIV-1 strains in a large batch to ob-
tain similar aliquots of one mixture of heterogeneous viral
haplotypes (Figure 1A). Three NGS technologies, namely,
454/Roche, Illumina and PacBio, were applied to sequence
the full-length genomes of the mixture of HIV-1 strains,
each requiring different protocols for sample preparation
and sequencing. For 454/Roche, 35 ∼500 bp long am-
plicons were generated by reverse transcriptase-PCR (RT-
PCR) overlapping in∼250 bp (all oligonucleotides are given
in Supplementary Table S1). For Illumina, five ∼2500 bp
long amplicons were obtained by RT-PCR overlapping in
∼500 bp. Amplicons were enzymatically fragmented (Nex-
tera tagmentation reaction) prior to sequencing, i.e. in con-
trast to the other two NGS technologies, we applied a shot-
gun approach for Illumina. For PacBio, eleven ∼1500 bp
long amplicons with ∼750 bp overlaps were amplified by
RT-PCR (Figure 1A).
Sequencing of HIV-1 full-length genomes was success-
ful for all amplicons, except amplicon 28 in the 454/Roche
setup. The coverage had an average (range) of 7712 (2237–
22 661), 23 010 (5084–47 232) and 1741 (450–3147), reads
per nucleotide, for 454/Roche, Illumina and PacBio, respec-
tively (Figure 1B). Average read lengths after pre-processing
and alignment were (mean ± sd) 410 ± 41 bp, 237 ± 26
bp and 1499 ± 77 bp for 454/Roche, Illumina and PacBio,
respectively (Figure 1C). To obtain the underlying ground
truth, each of the five virus stocks was sequenced separately
with Illumina prior to mixing them. Reads were aligned
against the respective GenBank reference genome and a
consensus sequence was called for each viral strain. As our
goal was to define a consensus sequence for each strain,
the coverage of high-quality reads was not sufficient to per-
form single-nucleotide variant (SNV) calling. Compared to
the published GenBank sequences for those virus strains,
we detected 2–36mismatches per HIV-1 strain (Supplemen-
tary Table S3). The pair-wise relative Hamming distances
of the 5-virus-mix were between 2.61% and 8.45% (Supple-
mentary Table S4).
Gene-wise haplotype reconstruction reduces false SNV calls
We assessed the quality of gene-wise haplotype reconstruc-
tion by comparing SNV calls and haplotype predictions
to the underlying ground truth for each of the three NGS
platforms. The accuracy of SNV calls derived from gene-
wise haplotype reconstructions was compared to the stan-
dard method based simply on alignment mismatches (Fig-
ure 2A). SNVs were called if their abundance was higher
than a given threshold. For standard SNV calling, this
threshold was the assumed technical error rate of 1%, ex-
cept for deletions in the PacBio data set, where the cutoff
was 5%, as the majority of PacBio errors are due to dele-
tions: 32.2% and 7.3%of the positions harbor deletions over
1% and 5%, respectively. For haplotype-based SNV call-
ing, all SNVs found on at least one reconstructed haplo-
type were called. Without haplotype reconstruction, SNV
calls that appeared in the reads but are missing in the five
ground truth sequences (false positives) were numerous and
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Figure 1. HIV-1 full-length genome sequencing using three different NGS technologies. (A) Experimental protocol. Five HIV-1 full-length plasmids were
transfected into 293T cells to generate five different virus stocks. These clones were mixed in a large batch and aliquoted. RNA was isolated and amplified
with three different protocols. DNA libraries were sequenced with either 454/Roche, Illumina or PacBio. (B) Coverage in overlapping reads per base pair.
The map of the HIV-1 genome is shown on the top, with each subsequently analyzed gene indicated. The position numbering refers to the HIV-1HXB2
genome (GenBank accession number K03455). Amplicon layout is visualized for each NGS platform with individual numbering (Supplementary Table
S1). (C) Read length distribution of each NGS technology, after preprocessing and alignment.
distributed all over the sequenced region, for PacBio and
454/Roche, but considerably less frequent for Illumina. The
false positive calls in the 454/Roche and PacBio data sets
were dominated by deletions, which are common errors for
these two technologies. Illumina sequence reads showed a
9- and 17-fold lower false positive rate than 454/Roche and
PacBio, respectively. SNVs that are present in the ground
truth reference sequences but were missing in the reads
(false negatives) were only found in regions with missing
amplicons (amplicon 28 for 454/Roche and variant HIV-
1YU2 in amplicon i for PacBio). Gene-wise haplotype recon-
struction, including both local and global reconstruction
depending on read and gene lengths, reduced the rates of
false positive calls substantially to 0.04%, 0.08% and 0.0%,
for 454/Roche, Illumina and PacBio, respectively (Figure
2B). Haplotype inference did not only eliminate insertion
and deletion errors, but also almost all substitution errors.
Comparing the false positive and false negative calls prior
and after haplotype reconstruction between the three NGS
technologies showed that the number of joint errors is low,
except for deletions, where a substantial number of gaps
were present in 454/Roche and PacBio sequence reads (Fig-
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Figure 2. SNV calling based only on the alignment (naı¨ve) versus haplotype reconstruction. (A) Distribution of SNVs across the full-length HIV-1 coding
region compared to the ground truths for each NGS platform, on top shown as directly obtained from the alignment and on the bottom after gene-wise
haplotype reconstruction. A SNV is called from the alignment, when its relative occurrence is higher than 1%, except for the deletions within the PacBio
data, where a threshold of 5% was applied. SNVs from inferred haplotypes are called if found in at least one reconstructed haplotype. False positive SNVs
and false negative SNVs are represented as upward and downward pointing bars, respectively. Bars are color coded for the four different nucleotides
and the gap-symbol, bars may stack for multiple false calls at a single position, and false positives and false negatives may occur at the same position.
(B) Co-occurrence of false positive and false negative SNVs among NGS platforms shown as Venn diagrams, with and without gene-wise haplotype
reconstruction.
ure 2B). However, these errors were successfully removed
during haplotype reconstruction.
Gene-wise haplotype reconstruction and frequency estima-
tion of HIV-1 variants
For each data set obtained from one of the three NGS
platforms, we reconstructed haplotypes and estimated their
frequencies on different spatial scales of the viral genome.
Haplotypes were inferred for each viral gene separately us-
ing QuasiRecomb (18). The five haplotypes were correctly
identified for all 13 HIV-1 genes using sequence reads ob-
tained from any of the three NGS platforms (Figure 3),
with the single exception of gp120 in the 454/Roche data,
where one amplicon was missing (amplicon 28, Figure 1B).
Successful amplification of all fragments is necessary, be-
cause missing overlaps generally disrupt haplotype recon-
struction. Out of 38 gene-wise reconstructions in total, all
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Figure 3. Gene-wise haplotype reconstruction. Haplotypes were reconstructed for the genes p17, p24, p2-p6 (functional regions in gag), PR, RT, RNase,
Int (pol, polymerase), gp120, gp41 (env, envelope) and the accessory genes vif, vpr, vpu and nef using QuasiRecomb. The five distinct HIV-1 strains are
color coded and their frequencies in each region are shown for each NGS platform. The length of each region is denoted in base pairs at the bottom of
each column together with the genetic distances of the five HIV-1 variants against each other in the corresponding regions. A number instead of a symbol
indicates the Hamming distance of the reconstructed haplotype to its closest match in the ground truth.
five virus variants were predicted in 36 genes without any
mismatch relative to the ground truth. In one case, from the
Illumina sequence reads, only four gp41 haplotypes were
perfectly reconstructed, because the relative Hamming dis-
tance between the two closest haplotypes is below 1%.Here,
the short sequence reads as obtained by Illumina were dis-
advantageous. In the other case, the reconstruction of HIV-
1YU2 gp120 had one mismatch relative to the ground truth
using the PacBio data set, because this base was only cov-
ered by the missing variant HIV-1YU2 in amplicon i (Figure
1B).
We previously estimated the frequencies of the virus
strains in the 5-virus-mix by amplifying the protease gene
using single-genome amplification (SGA) (20), the current
gold standard for studying diversity of virus populations
(25). Here, we used those data for comparison with the
NGS-based frequency estimates (Figure 3). For each NGS
platform, the gene-wise median haplotype frequencies did
not differ significantly from those obtained by SGA (Ta-
ble 1, p = 0.9776, Kruskal–Wallis test (26)). However, fre-
quency estimates did fluctuate locally between genes.
Global haplotype reconstruction of HIV-1 full-length
genomes
5-virus-mix. Next, we extended global haplotype recon-
struction first to theHIV-1 gag-pol region spanning 4036 bp
and subsequently to the entire coding region ofHIV-1 span-
ning a total of 8627 bp (referred to as full-length, despite the
omitted non-coding regions of the long terminal repeats).
In the gag-pol region, all five virus strains were perfectly
reconstructed using either QuasiRecomb or PredictHaplo
(Figure 4). Sequence reads from all three NGS platforms
were suitable for global reconstruction of the entire gag-pol
region. For full-length haplotype reconstruction, we assem-
bled reads over a genomic region six times longer than the
∼1.5 kb long amplicons used for PacBio single-molecule se-
quencing. With PacBio data, haplotype reconstruction us-
ing QuasiRecomb was almost error-free with only a single
mismatch in HIV-1YU2 relative to the closest ground truth
(Figure 4). Using PredictHaplo, we also reconstructed all
five haplotypes correctly, but only three haplotypes passed
PredictHaplo’s internal quality control (Figure 4); exclusion
of two haplotypes was due to insufficient overlap of reads.
For the short Illumina reads, no haplotype passed Predic-
tHaplo’s conservative quality control, but full-length recon-
struction was successful with QuasiRecomb, allowing only
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Table 1. Estimated frequencies of reconstructed haplotypes across genes
Estimated frequencies% (mean ± sd)a
Sequencing
technology HIV-1 89.6 HIV-1 HXB2 HIV-1 JR-CSF HIV-1 NL4–3 HIV-1 YU2
454/Roche 13.7 ± 5.1 11.0 ± 2.4 18.2 ± 8.6 46.2 ± 12.9 10.9 ± 3.5
Illumina 22.1 ± 3.9 11.2 ± 5.9 28.0 ± 7.3 27.3 ± 9.2 11.1 ± 3.2
PacBio 16.5 ± 9.7 5.8 ± 2.6 27.2 ± 6.4 35.9 ± 7.9 14.6 ± 6.2
SGA 12.3 ± 2.3 9.2 ± 3.3 27.9 ± 4.6 38.4 ± 3.2 12.2 ± 0.7
NGS, next-generation sequencing.
aFor the NGS platforms (columns 1–3), the mean and standard deviation of each frequency across all 13 gene-wise predictions are reported. For single
genome analysis (SGA), the estimates are based on three replicates with 168, 156 and 148 protease sequences.
Figure 4. Global haplotype reconstruction of theHIV-1 gag-pol genomic region and of full-length genomes. Estimated frequencies are shown for theHIV-1
gag-pol region and the full-length coding region for each data set and each computational method. Gray shaded areas represent haplotypes that did not
pass quality control; white striped area shows reconstructed HIV-1HXB2 with a Hamming distance of nine. The white number in the QuasiRecomb result
indicates the Hamming distance to the closest ground truth. For comparison, the mean gene-wise frequencies for each data set using QuasiRecomb and
the frequencies of each virus strain detected by SGA of the protease gene in three independent experiments (20). Numbers of analyzed clones are given
below each bar.
nine mismatches for HIV-1HXB2 in gp41 (Figure 4). We per-
fectly recovered the first 5272 bp of the HIV-1 coding region
when using the 454/Roche data, but the assembly was dis-
continued due to themissing amplicon 28.Whenwemerged
the 454/Roche and PacBio data sets, all positions were cov-
ered by amplicons with sufficient overlap, and perfect full-
length haplotype reconstruction was achieved using either
PredictHaplo or QuasiRecomb (Figure 4). The frequency
estimates were almost identical between the different NGS
technologies and were also in agreement with the SGA re-
sults. Fluctuations in variant frequencies were substantially
reduced for the frequency estimates based on the full-length
reconstructed haplotypes with standard deviations around
one order of magnitude smaller than for the gene-wise re-
construction (Tables 1 and 2).
Patient’s samples. The first sample of this patient (sam-
ple A) was obtained ∼7 weeks after estimated day of pri-
mary HIV-1 infection (Figure 5A). Antiretroviral therapy
was started at this time point and interrupted at week 91 ac-
cording to the study protocol. The second sample (sample
B) was obtained at week 99. Superinfection with a second
HIV-1 strain presumably occurred within the weeks follow-
ing week 91 as primarily revealed by extensive clonal env
sequencing in two independent laboratories. At week 7, 9/9
env clones contained one haplotype and at week 107, 4/8
env clones contained another, distinct haplotype and the re-
maining 4 clones were recombinants between the first and
the superinfecting HIV-1 strains.
Samples A and B were sequenced using the Illumina and
Pacific Biosciences platforms. The coverage had an aver-
age (range) of 168 401 (30 650–255 500) and 3203 (1940–
5524) reads per nucleotide, respectively. At week 7, we re-
constructed a single full-length haplotype in the virus pop-
ulation. After superinfection at week 99, two haplotypes
with frequencies of 97.2% and 2.8% were reconstructed by
QuasiRecomb from the Illumina reads in a window that
covered gp41 of the env region. The env clones were used to
validate the reconstructed haplotypes and indeed, the hap-
lotypes with frequencies of 97.2% and 2.8% matched with
zero and two base pair mismatches to env clones of weeks 99
and 7, respectively. Sequence dissimilarity between the two
haplotypes was 10.5%.
For global, i.e. genome-wide, haplotype reconstruction,
we changed the computational setup in two important
PAGE 9 OF 12 Nucleic Acids Research, 2014, Vol. 42, No. 14 e115
Table 2. Estimated frequencies of reconstructed haplotypes over the full-length coding region
Estimated frequencies% (mean ± sd)a
NGS platform HIV-1 89.6 HIV-1 HXB2 HIV-1 JR-CSF HIV-1 NL4–3 HIV-1 YU2
454/Roche 14.4 ± 0.4 11.0 ± 0.4 19.9 ± 0.5 43.5 ± 1.0 11.1 ± 0.4
Illumina 22.6 ± 0.3 10.0 ± 0.4 29.6 ± 0.4 26.9 ± 0.4 10.9 ± 0.3
PacBio 17.6 ± 0.3 5.9 ± 0.5 27.1 ± 0.5 36.2 ± 0.5 13.1 ± 0.4
NGS, next-generation sequencing.
aFor each platform, we computed mean and standard deviation of full-length reconstructed haplotype frequencies of 100 bootstrap samples from 179 521;
1 365 693 and 10 651 reads for 454/Roche, Illumina and PacBio, respectively.
Figure 5. Global haplotype reconstruction of HIV-1 in an HIV-1 superinfected patient. (a) HIV-1 RNA load (black circles) and estimated time of superin-
fection (gray shaded area). Depicted are time points A (∼7 weeks after primaryHIV-1 infection) and B (∼99 weeks after primaryHIV-1 infection) that were
chosen for HIV-1 full-length sequencing using the Illumina platform. Global haplotype reconstruction was performed using both computational methods,
data obtained with the PredictHaplo model are depicted. The dotted line shows the detection limit of the viral load assay (40 HIV-1 RNA copies/ml
plasma). (b) Mismatches between haplotype 1 (HT 1) to the haplotype from week 7 are shown as gray vertical lines within the HIV-1 gene map. (c and d)
Sequence logo representation of all five reconstructed haplotypes (HT1 – HT 5) and the respective haplotype from week 7 in a window between position
2300 and 2800 (c) and between 6100 and 6500 (d). The frequency information in the sequence logos reflects the statistical properties of the PredictHaplo
model, where haplotypes are represented as chains of probability tables over the four nucleotides plus gaps. Shown are only positions where at least one
haplotype differs from the others.
details: first, we used the PredictHaplo software which
is specifically tailored for this purpose and contrary to
QuasiRecomb which is more suitable for gene-wise re-
constructions, and second, the Illumina reads were com-
bined with the much longer PacBio reads to ensure suf-
ficient overlaps around all amplicon borders. Global re-
construction with PredictHaplo based on these combined
Illumina/PacBio reads yielded five global haplotypes at
week 99. One of these haplotypes closely resembled the sin-
gle full-length haplotype fromweek 7.On thewhole genome
these two sequences differ only at 16 positions (Figure 5B).
Probably due to primer bias, the frequency estimate for
this haplotype varied with the position in the genome, but
the small median frequency over all positions of only 1.9%
clearly indicates that this was a minor variant at week 99.
The composition of all five reconstructed haplotypes var-
ied over the whole genome. While in some local windows,
four of the haplotypes (HT 1–HT 4) were composed of lo-
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cal variations of the sequence from week 7 and only one
haplotype (HT 5)was substantially different (Figure 5C and
D). In other local windows we foundmore complicated pat-
terns that indicate the presence of at least three major vari-
ants and recombination events. Recombinant haplotypes of
week 7 and week 99 have been reconstructed by Predic-
tHaplo and QuasiRecomb. The number of recombination
events varied spatially, from no recombination in gp41 to
up to 19 recombination sites in the first 500 bp of the pol-
region. We focused on gp41 of the env region in which two
variants were detected with QuasiRecomb. A comparison
with the five global haplotypes identified by PredictHaplo
corroborates these previous findings: In this region, three
of the five global haplotypes are identical and match per-
fectly to the dominating sequence found by QuasiRecomb,
i.e. the sequence of the env-clones of week 99. These three
haplotypes together have an estimated frequency of 98.1%,
which is also very close to the QuasiRecomb frequency esti-
mate. From the remaining 1.9% of the virus population, one
global haplotype matches perfectly to the minor env variant
found by QuasiRecomb, i.e. the env-clones of week 7. The
last of the five global haplotypes might be a recombination
of these two sequences, but given the tiny fraction of this
haplotype and the relatively high diversity of the associated
reads, this interpretation is not entirely clear. Further, such
a recombination could not be verified by QuasiRecomb.
DISCUSSION
We have shown that global haplotype reconstruction of dis-
tinct viral genomes within a heterogeneous virus population
is feasible using short sequence reads of a mixture of HIV-1
haplotypes in defined combinations of HIV-1 strains as well
as in a real patient’s sample. Perfect global reconstruction
and correct frequency estimation were accomplished apply-
ing three different NGS platforms, namely, 454/Roche, Il-
lumina and PacBio, despite their differences in read length,
coverage and error patterns (3). Each of these technologies
has specific advantages and disadvantages when used for vi-
ral haplotype reconstruction. Besides NGS technology, vi-
ral haplotype assembly also depends critically on the genetic
heterogeneity of the underlying population and the diversity
distribution along the genome.
454/Roche offers intermediate read length and coverage,
and the errors occur mainly in homopolymeric regions (27).
However, this technology is very labor-intensive and re-
quires a high number of amplicons to cover the complete
HIV-1 genome with sufficient overlap of neighboring am-
plicons, which increases the risk of interruptions in global
haplotype reconstruction. Indeed, in our data set, the miss-
ing amplicon 28 (out of 35) in the 454/Roche data pre-
vented full-length haplotype reconstruction. Illumina gen-
erates short reads at very high coverage and a low error rate
(28). Full-length genomes of four out of five HIV-1 haplo-
types were perfectly reconstructed, but the fifth haplotype
could not be reconstructed correctly. The viral gene gp41 in
the variants HIV-1HXB2 and HIV-1NL4–3 shows a distance
of less than 1%, which is below the assumed technical error
rate. The short read length did not allow to bridge this re-
gion of low diversity, thus, full-length haplotype reconstruc-
tion was only partly successful based on the Illumina data
set. This finding shows that high coverage and low error
rates cannot compensate for short read length. Pacific Bio-
sciences enables long read length, but the coverage per run
is low and the error rate high (29). Nevertheless, using this
data set alone, perfect full-length haplotype reconstruction
of all five HIV-1 viruses was successful. One mismatch was
observed in the reconstructedHIV-1YU2 strain compared to
the ground truth. This virus was not successfully amplified
in one of 11 amplicons for the PacBio procedure. For gene-
wise reconstruction, we have shown that a minimal relative
Hamming distance of 1% is sufficient for successful recon-
struction.
All three NGS technologies enabled perfect reconstruc-
tion of the entire gag-pol region of over 4000 nucleotides
thereby exceeding the current maximal read length by sev-
eral fold. We observed fluctuations in haplotype frequen-
cies performing gene-wise reconstruction that most proba-
bly were due to PCRartifacts especially in the 454/Roche or
PacBio data sets. Amplification biases can lead to the loss
of a haplotype during PCR, either by primer mismatches
or the potential PCR artifact of differential amplification
or the combination of both (17,30,31), and therefore influ-
ence the frequency estimations of viral variants. We ruled
out that coverage, genetic distance or read length caused
these fluctuations (data not shown). However, we observed
that these fluctuations were substantially reduced when we
expanded the global haplotype reconstruction to the entire
gag-pol or even the full-length genome. This shows that am-
plification biases can be averaged out by including several
amplicons in the global haplotype reconstruction.
A recent study by Prosperi et al. (32) measured the per-
formance of different assembly methods, including Predic-
tHaplo but not QuasiRecomb. They used a mixed popula-
tion with 20 genetically different HIV-1 variants of which
they tried to reconstruct a 1.4 kb long region based on 350
bp long reads. Despite the six times shorter region than
the full-length HIV-1 genome, none of the tested programs
was able to reconstruct more than six correct haplotypes
and all of them produced false positive haplotypes. We have
improved and extended existing haplotype reconstruction
methods considerably to accomplish HIV-1 full-length as-
sembly. Specifically, we have developed a hierarchical as-
sembly strategy based on QuasiRecomb’s inference model,
and we have introduced quality scoring as well as paired-
end support to PredictHaplo. Both extensions are essen-
tial and the resulting methods are the first probabilistic
models capable of HIV-1 full-length haplotype assembly.
The more conservative approach of PredictHaplo avoids
false positive calls, but may miss haplotypes if they can-
not be explained by sufficiently overlapping reads. On the
other hand, QuasiRecomb is less strict leading to a higher
quote of reconstructed haplotypes, but it requires several
restarts of the optimization procedure to obtain the cor-
rect haplotypes. Both methods could be further improved
in several ways. For example, read alignment could be in-
tegrated into the reconstruction process to better handle
insertions/deletions. In QuasiRecomb, deletions may be
modeled explicitly as long jumps between generators to ac-
count for the alignment uncertainty in deletion-prone re-
gions. When it comes to comparing the two software tools,
we suggest as a general rule to use QuasiRecomb for gene-
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wise diversity and recombination studies, and themore con-
servative but computationally more efficient PredictHaplo
software for genome-wide reconstructions.
In conclusion, we have shown that reconstruction of
whole genomes from a sufficiently heterogeneous virus pop-
ulation is feasible using a variety of differentNGS technolo-
gies. The most apparent difficulty in global reconstruction
of haplotypes is the reconstruction of regions with low di-
versity. The sequence read overlaps need to be long enough
to bridge such conserved region. The data generated in this
study is based on the same mixture of HIV-1 strains using
three of the most common NGS platforms. It can be used
to benchmark current and upcoming tools for global haplo-
type reconstruction. Furthermore, as a proof of concept for
future in vivo studies we successfully applied our approach
to a well characterized intraclade superinfection case as de-
fined by conventional clonal env sequencing. We were able
to reconstruct the initial founder haplotype. After superin-
fection, we could reconstruct the haplotype of the superin-
fecting strain which was present at a frequency of 99%. In
addition, we were able to find the initial founder haplotype
again at a very low frequency of ∼2% after superinfection
has occurred and the new superinfecting haplotypes in ad-
dition to recombinants were responsible for ∼98% of the
virus population at week 99. Of note, by conventional clonal
sequencing the initial founder strain could not be detected
at this time point. Since the first case of superinfection was
described (33), it is worried that superinfection could have
detrimental implications on HIV therapy and future vac-
cines, thus, more detailed investigations of virus popula-
tions in HIV-1 superinfected patients are needed. Taken to-
gether our single-haplotype genomics approach provides a
powerful instrument to investigate the evolution of HIV-1
and other viruses also in vivo.
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